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Galectin-3 deﬁciency drives lupus-like disease by
promoting spontaneous germinal centers formation
via IFN-γ
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Germinal centers (GC) are important sites for high-afﬁnity and long-lived antibody induction.
Tight regulation of GC responses is critical for maintaining self-tolerance. Here, we show that
Galectin-3 (Gal-3) is involved in GC development. Compared with WT mice, Gal-3 KO mice
have more GC B cells and T follicular helper cells, increased percentages of antibody-
secreting cells and higher concentrations of immunoglobulins and IFN-γ in serum, and
develop a lupus-like disease. IFN-γ blockade in Gal-3 KO mice reduces spontaneous GC
formation, class-switch recombination, autoantibody production and renal pathology,
demonstrating that IFN-γ overproduction sustains autoimmunity. The results from chimeric
mice show that intrinsic Gal-3 signaling in B cells controls spontaneous GC formation. Taken
together, our data provide evidence that Gal-3 acts directly on B cells to regulate GC
responses via IFN-γ and implicate the potential of Gal-3 as a therapeutic target in
autoimmunity.
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B cell function provides a key line of defence against infec-tions through the production of high afﬁnity antibodies,which are critical for clearing pathogens and preventing
reinfections. These antibodies are the main product of long-lived
antibody-secreting cells (ASCs) or plasma cells (PCs), which are
generated with the help of a distinct subset of CD4+ T cells called
T follicular helper (Tfh) cells, within a specialised micro-
environment known as the germinal center (GC)1–3. The GC
contains highly proliferative B cells that undergo Ig somatic
hypermutation and isotype switching, in which B cells are also
selected based on their antigen afﬁnity. Indeed, GCs are an
important B cell–tolerance checkpoint in the periphery. IL-4 and
IL-21 are the most important cytokines for assisting B cells during
the differentiation process to GC B cells, and mice that are
deﬁcient for both IL-4 and IL-21 receptors (Il4−/−Il21r−/− mice)
were found to have severe defects in antibody production and GC
formation4.
Although GC activity is fundamental for health by inducing
protective immunity, overreactivity of the GC pathway causes
autoimmunity. Dysregulated GC B cell and Tfh responses make
decisive contributions to the generation of class-switched auto-
antibodies and to the development of lupus in several mouse
models5–8. Associations between autoimmunity and overactive
GCs have also been suggested in human systemic lupus erythe-
matosus (SLE), Sjogren’s syndrome, rheumatoid arthritis, and
autoimmune thyroid disease9. Vinuesa and collaborators10 have
demonstrated that the reduction of GC cell numbers caused by
the speciﬁc deletion of one allele of Bcl6 ameliorates the auto-
immune pathology observed in Roquinsan/san (sanroque) mice,
which develop GCs in the absence of foreign antigen. A reduction
of spontaneous GC formation via the blockade of T cell signaling
in different autoimmune experimental models also reduces
disease6,7,11. Thus, a ﬁne equilibrium between GC formation and
number is required for tolerance.
GC formation and B cell differentiation to PCs is strictly
regulated by several transcription factors12. Bcl-6 and Blimp-1 are
transcriptional repressors with the ability to block each other’s
expression. Bcl-6 is expressed by GC B cells and is required for
this phase of B cell development. Bcl-6-deﬁcient mice lack GC B
cells and afﬁnity maturation. Constitutive expression of Bcl-6 in B
cells in vivo results in a large GC. In addition, three studies have
shown that Bcl-6 is a master regulator of Tfh differentiation13–15.
PC differentiation, in contrast, critically depends on Blimp-1
expression and the absence of Bcl-6. Blimp-1 is highly expressed
in PCs and controls many genes that are important for PC dif-
ferentiation. Furthermore, this transcription factor also inhibits
genes involved in cellular proliferation, such as Myc and Bcl6,
thereby allowing the terminal differentiation of PC16.
Although much progress has been made in understanding the
factors and rules that govern the generation of GCs and the
formation of long-lived ASCs during infections and auto-
immunity, the identiﬁcation of new molecules is crucial to
achieve a better understanding of this complex process. This is a
pivotal issue not only for the design of vaccines against pathogens
and malignant cells but also for therapeutic intervention in
autoimmunity.
We and others have shown that the downregulation or deﬁcit
of Galectin-3 (Gal-3) leads to an increase in the number of ASCs
during the course of Trypanosoma cruzi and Schistosoma man-
soni infection17,18 and promotes peritoneal B1 cell differentiation
into PCs19. Moreover, B cells with reduced expression of endo-
genous Gal-3 fail to down-regulate Blimp-1 after IL-4 stimula-
tion17. Hoyer and collaborators have demonstrated that Gal-3 is
present in naive and memory B cells but almost absent in dif-
ferentiated B cells, such as CD10−/IgD− GC B cells, and PCs20.
Taken together, these ﬁndings support the hypothesis that Gal-3
may inﬂuence GC and ASC generation.
Gal-3 belongs to the large growing family of highly conserved
β-galactoside binding lectins known as galectins. Gal-3 is the only
chimera-type galectin composed of an unusual non-lectin proline
and glycine-rich domain coupled to a carbohydrate-recognition
domain21. Gal-3 has a broad distribution among different types of
cells and tissues. It can be localised intracellularly, in the nucleus
and cytoplasm, or extracellularly, secreted via the non-classical
pathway22. Relying on its expression level, the type of cell and the
speciﬁc immune condition, Gal-3 can be either a positive or a
negative regulator of the immune response23–25. Considering that
Gal-3 is expressed in B cells17,20 and T cells and that the down-
regulation of Gal-3 improves antigen-speciﬁc antibody produc-
tion17, we explored whether Gal-3 could inﬂuence the GC reac-
tion and B cell differentiation into ASCs, processes that involve a
delicate crosstalk between B and T cell populations.
Our study reveals previously unrecognised functions of Gal-3
in the regulation of GC responses. The absence of Gal-3 in mice
drives an excess of IFN-γ, which leads to aberrant GC formation
and autoantibody production. This study reveals Gal-3 as a key
factor in the development of IFN-γ-mediated lupus-like disease.
Results
Gal-3 has a critical function in GC formation. To investigate the
Gal-3 expression pattern in differentiated B cells, puriﬁed splenic
B cells were stimulated with LPS or anti-CD40 plus IL-4 to induce
differentiation into ASCs. Figure 1a shows that Gal-3 protein was
detectable in splenic B cells and its expression decreased to
undetectable and very low levels in LPS-stimulated and anti-
CD40 plus IL-4-activated B cells, respectively. To deﬁne the
kinetics and pattern of Gal-3 downregulation upon B cell dif-
ferentiation induced by LPS, splenic B cells were cultured alone or
with LPS for different times. While the Gal-3 protein level rose in
B cells cultured for 48 and 72 h without stimuli, it became
completely undetectable after 48 h of LPS stimulation (Fig. 1a).
As LPS is an inducer of PC differentiation26, the above-
described results suggest that a decrease in Gal-3 expression can
be associated with antibody secretion. Thus, we next compared
Gal-3 expression between peritoneal B1 and splenic B2 cells with
differential abilities to spontaneously secrete Igs. We observed no
differences in Gal-3 expression among these two B cell subsets
(Supplementary Fig. 1a). Additionally, Gal-3 was also detectable
in T cells, and this expression was substantially lower than in B
cells (Supplementary Fig. 1a). In agreement with previous
reports27, speciﬁc ﬂuorescence staining for Gal-3 was detected
in both the nucleus and cytoplasm of non-stimulated resting B
cells (Supplementary Fig. 1b, upper panels), and a remarkable loss
of ﬂuorescence intensity was observed when B cells were
stimulated with LPS (Supplementary Fig. 1b, lower panel). These
ﬁndings indicate that the differentiation of B cells to ASCs is not
associated with a sub-cellular redistribution of Gal-3 protein but
rather a reduction of protein synthesis. Indeed, stimulation of B
cells with LPS induced a down-regulation of the transcript
encoding Gal-3 (Supplementary Fig. 1c). Gal-3 mRNA levels were
signiﬁcantly down-regulated after 24 and 48 h of LPS stimulation
with respect to the transcript level at 12 h (p < 0.001 by one-way
ANOVA). In agreement with the protein expression level
(Fig. 1b), B cells cultured in the absence of stimulation had
similar Gal-3 mRNA levels at 12 and 24 h, but a signiﬁcant
upregulation (p < 0.01 by one-way ANOVA) was detected after
48 h of culture with medium (Supplementary Fig. 1c).
To address the role of Gal-3 in B cell immunobiology in vivo,
we took advantage of Gal-3 KO mice. We ﬁrst compared the
concentration of serum antibodies and the frequency of splenic
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and bone marrow ASCs in Gal-3 KO and WT mice. We found
that, without purposeful immunization or infection, Gal-3 KO
mice displayed signiﬁcantly (p < 0.001 by unpaired Student's t-
test) higher concentrations of IgM, IgG2c, and IgG3 in serum
(Fig. 1c), as well as higher frequencies of IgM and IgG ASCs in
spleen and bone marrow (Fig. 1d), in comparison to WT mice.
Considering that production of antibodies under homoeostatic
conditions relies on different B cells subsets and can be produced
by ASCs derived or not from the GC, we examined the frequency
of different mature B cells (follicular, FO, and marginal zone, MZ,
B cells), GC B cells and PCs in spleen from Gal-3 KO and WT
mice. We found no signiﬁcant differences (p > 0.05 by unpaired
Student's t-test) in the absolute number of FO and MZ B cells
between the groups of mice (Fig. 1e), but Gal-3 KO mice had a
signiﬁcantly greater number of GC (B220+ FAS+ GL7+ CD3−
CD11b− CD11c−) and PC (B220int CD138+ CD3−) B cells
(Fig. 1f–h) compared with their WT counterparts (p < 0.001 and
p < 0.01 by unpaired Student's t-test, respectively). The phenotype
of GC B cells was conﬁrmed by low levels of IgD and CD38
(Supplementary Fig. 2a–c) and high levels of CXCR4 and CD40
expression, and a high frequency of Ki-67+ cells within B220+
GL7+ FAS+ B cells, in comparison to the phenotype exhibited by
non-GC B cells (B220+ GL7− FAS−) (Supplementary Fig. 2d–f,
respectively). Immunoﬂuorescence analysis of spleen sections
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revealed larger spontaneous PNA++ GCs within the follicles in
Gal-3 KO mice, whereas WT mice showed a complete absence of
GCs (Fig. 1i).
When we analysed the presence of Tfh cells, identiﬁed as CD4+
CXCR5+ ICOS+ Foxp3− T cells, in Gal-3 KO mice, we observed
that, in clear contrast to the few Tfh cells observed in WT mice,
the spleen of Gal-3 KO mice exhibited an exacerbated frequency
of Tfh cells (Fig. 1j). We veriﬁed the Tfh cell identity based on the
high PD-1 and Bcl-6 expression (Supplementary Fig. 3a–d). We
also examined Tfr cells, a subset of CD4+ Foxp3+ Treg cells
within the GC that coopt a CXCR5+ ICOS+ phenotype and limit
the magnitude and output of the GC response. Among CD4+
CXCR5+ ICOS+ T cells, the frequency of Tfr cells was reduced in
Gal-3 KO mice in comparison to WT (Fig. 1k). However, the total
Treg (CD4+ Foxp3+ CD25+) frequency and number were similar
in both groups of mice (Supplementary Fig. 4a), and there were
no differences in expression of the regulatory molecules CTLA-4
or CD39 on Treg cells between WT and Gal-3 KO mice
(Supplementary Fig. 4b, c, respectively). Of note, the Tfh/Tfr
ratio, which is an important factor in humoral immunity because
it dictates the magnitude of antibody responses28, was increased
in Gal-3 KO mice. Taken together, these results indicate that the
absence of Gal-3 drives spontaneous GC formation and,
consequently, Igs production.
Gal-3-deﬁcient B cells express GC-associated molecules. To
investigate whether Gal-3 affects the transcriptional programme
of B cells, we performed gene expression proﬁling by microarray
using puriﬁed B cells from spleens of WT and Gal-3 KO mice
(Fig. 2a). Heat maps highlighted the most differentially expressed
transcript of genes that are relevant for GC biology (Fig. 2a).
Remarkably, the levels of transcripts encoding Igs and molecules
associated with the GC B cell phenotype and function, such as
Gcet229 and H2B30; the indicator of proliferation Mki67 and the
critical component of antibody class-switching Aicda were
upregulated in B cells from Gal-3 KO mice. In accordance with
spontaneous GC formation, the array analysis showed an upre-
gulation of two genes encoding miRs associated with the GC
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Fig. 2 B cells from Gal-3 KO mice had increased expression of genes related to GC formation and costimulatory molecules. a Heat maps of the expression
of selected genes related to the GC reaction determined in B cells from WT and Gal-3 KO mice (n= 2 for both strains). b Statistical analysis of the
frequency of CD80+, CD86+, IL-21R+, CXCR4+, Ki-67+, and CD69+ B220+ B cells from the spleen of 8-week-old WT and Gal-3 KO mice (n= 6 for both
strains). c Radar plots summarising the B cell phenotype observed in the spleen of Gal-3 KO and WT mice (n= 6 for both strains). Data are the mean ± s.e.
m. *p < 0.05, **p < 0.005 (unpaired Student’s t-test). a Data are representative of two independent experiments. b, c Data are representative of three
independent experiments
Fig. 1 Downregulation of Gal-3 during PC differentiation and increased concentration of Igs and spontaneous GC formation in Gal-3 KO mice. a Splenic B
cells were cultured with medium, LPS, or anti-CD40 plus IL-4 for 72 h, and Gal-3 expression was evaluated by western blot analysis. The Gal-3 signal was
normalised to β-Actin (n= 5 for each condition). b Splenic B cells were cultured medium or LPS from 12 to 72 h. The Gal-3 signal was normalised to
calreticulin (n= 3 for each condition). c Quantiﬁcation by ELISA of IgM, IgG1, IgG2c, IgG2b, and IgG3 in sera from 8-week-old WT and Gal-3 KO (n= 11 for
both strains) mice. d Representative images (left) from the ELISPOT assay of IgG-ASCs in the spleen and BM and statistical analysis (right) of IgM and IgG
ASCs in the spleen and BM from 8-week-old WT and Gal-3 KO mice (n= 5 for both strains). e Numbers of splenic MZ B cells and FO B cells determined
by ﬂow cytometry in WT and Gal-3 KO mice (n= 6 for both strains). f Numbers of splenic GC B cells and PCs determined by ﬂow cytometry in WT and
Gal-3 KO mice (n= 6 for both strains). g, h Representative plots and statistical analysis of splenic GC B cells (g) and PCs cells (h) in WT (n= 6) and Gal-3
KO (n= 8) mice. i Immunoﬂuorescence of spleen sections (7 μm) from WT and Gal-3 KO mice, indicated as KO, stained with PNA (green), anti-B220
(red), and anti-CD3 (blue). Magniﬁcation: ×100 (top) and ×200 (bottom) (n= 6 for both strains). Scale bar: 200 μm (upper panels), 100 μm (lower
panels). j Representative plots and statistical analysis of splenic Tfh cells in WT and Gal-3 KO mice (n= 6 for both strains). k Representative plots and
statistical analysis of the ratio between splenic Tfh and Tfr cells in WT (n= 6) and Gal-3 KO (n= 8) mice. Data are the mean ± s.e.m. *p < 0.05, **p <
0.005, ***p < 0.001. ns, not signiﬁcant (unpaired Student’s t-test). a–k Data are representative of three independent experiments. WT mice are indicated in
green and Gal-3 KO mice in blue
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reaction: miR-15531,32 and miR-21733. The absence of Gal-3 in B
cells resulted in a downregulation of miR-181b-1, the decrease of
which is also associated with the GC response and lupus34. The
gene and surface molecule expression proﬁle of Gal-3 KO-derived
B cells highlighted that the absence of Gal-3 favors an activation
phenotype that is prone to differentiate into GC B cells. To gain
further insights into the overall impact of the absence of Gal-3
signaling on B cells, we determined the expression of markers
involved in the GC reaction. We observed that IL-21R, a key
cytokine receptor involved in the regulation of the Bcl-6 and GC
response35, was expressed at a higher frequency on B cells from
Gal-3 KO in comparison to WT (Fig. 2b, c). We also found a
higher percentage of CD80-expressing and CD86-expressing B
cells in Gal-3 KO mice compared with their WT counterparts
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(Fig. 2b). In addition, we analysed molecules indicative of the
activation status of the cells and observed that Gal-3 KO mice had
higher percentages of CD69+ and Ki-67+ B cells (Fig. 2b); the last
one is a marker widely used to identify cells undergoing active
division, in agreement with the presence of spontaneous GC
development. Radar plots summarise the B cell phenotype
observed in spleen of Gal-3 KO and WT mice (Fig. 2c) and clearly
show that B cells from Gal-3 KO mice exhibit a higher frequency
of GC formation-related molecules.
Gal-3 acts directly on B cells to regulate GC responses. Next, we
wanted to address whether Gal-3-deﬁcient B cells have the cap-
ability to spontaneously differentiate and secrete Igs in the
absence of Ag stimulation and within a Gal-3-sufﬁcient physio-
logical environment. To achieve this goal, we performed two
different adoptive transfer experiments. First, total puriﬁed sple-
nic B cells from WT or Gal-3 KO mice were transferred to B cell-
deﬁcient μMT hosts, and the levels of antibodies were quantiﬁed
in sera two weeks after reconstitution (Fig. 3a). Sera from mice
transferred with Gal-3-deﬁcient B cells presented a higher con-
centration of IgG2c and IgG3 than sera from recipients of B cells
from WT (Fig. 3a). As expected, sera from μMT that did not
receive cells had undetectable Igs.
In a second approach, we transferred sorted GL7− Fas− B cells
(non-GC B cells) from WT or Gal-3 KO mice into WT recipients
(Fig. 3b). Sera from WT mice that received non-GC Gal-3-
deﬁcient B cells had a higher concentration of IgG2c and IgG3
than unmanipulated WT mice or WT mice transferred with Gal-
3-sufﬁcient non-GC B cells (Fig. 3b).
Next, we assessed the impact of endogenous Gal-3 deﬁciency
on the ability of B cells to produce antibodies in vitro. To achieve
this goal, we cultured sorted GL7− Fas− B cells fromWT or Gal-3
KO mice with sorted CD4+ T cells from WT or Gal-3 KO mice in
the presence of anti-IgM and anti-CD3 (Fig. 3c). Gal-3 KO B cells
produced larger amounts of IgG2c and IgG3 than WT B cells,
independently of the presence of CD4+ T cells from Gal-3 KO or
WT mice. All the results described above support the concept that
B cell-intrinsic Gal-3 deﬁciency promotes spontaneous antibody
secretion and, probably, spontaneous GC formation.
To directly test this idea, we generated mixed bone marrow
(BM) chimeras in which the absence of Gal-3 was limited to the B
cell compartment by reconstituting lethally irradiated C57BL/6
recipients with 80% μMT BM together with 20% Gal-3 KO BM
(μMT plus Gal-3−/− KO, Fig. 3d). The control group (μMT plus
Gal-3+/+ WT, Fig. 3d) consisted of irradiated mice reconstituted
with an 80:20 mix of μMT and Gal-3-sufﬁcient WT BM. Two
months after reconstitution, B cell-restricted Gal-3-KO chimeras
developed an evident splenic GC reaction, as reﬂected by FACS
analysis. A signiﬁcant increase (p < 0.05 by unpaired Student's t-
test) in Fas+ GL7+ GC B cells (Fig. 3e) and CD4+ CXCR5+ ICOS+
Tfh (Fig. 3f) was observed in the recipients of μMT plus Gal-3−/−
KO BM in comparison to the recipients of μMT plus Gal-3+/+WT
BM. Similar to Gal-3KO mice, B220+ and CD4+ T cells from B
cell-restricted Gal-3 KO chimeras presented higher percentages of
Ki-67+ cells than their counterparts in the B cell Gal-3-sufﬁcient
chimeras (Fig. 3g).
Next, we decided to assess whether the haematopoietic cells
from Gal-3 KO mice could inﬂuence the response of Gal-3-
sufﬁcient B and T cells from WT mice. To achieve this goal, we
developed chimeric mice in which lethally irradiated C57BL/6
mice were reconstituted with a 70:30 mix of CD45.1 Gal-3+/+
WT and CD45.2 Gal-3−/− KO BM, respectively (Fig. 3h). After
two months of BM cell injection, we detected a signiﬁcantly
higher percentage of B cells with the GC phenotype (B220+ Fas+
GL7+ CD4−) and Tfh (CD4+ CXCR5+ ICOS+), as well as Ki-67
+ B220+ B cells and CD4+ T cells, among the CD45.2+ Gal-3−/−
KO cells than the CD45.1+ WT counterparts (Fig. 3i–k,
respectively) (p < 0.05, p < 0.001, and p < 0.001 by paired Student's
t-test, respectively). This result indicated than Gal-3 KO cells did
not inﬂuence B and T cell responses in Gal-3-sufﬁcient mice.
Increased IFN-γ-producing CD4+ T cells in Gal-3 KO mice.
Because Gal-3 KO mice had a particular serum Ig isotype proﬁle,
we investigated whether this pattern correlated with a speciﬁc
type of T cell response deﬁned by cytokine production. Cytokines
secreted by Tfh cells and other cells within the GC niche inﬂuence
both the growth, survival, and differentiation of ASCs as well as
the differentiation of Tfh cells in an autocrine manner35,36. We
observed that, following anti-CD3/CD28 stimulation, puriﬁed
CD4+ T cells from Gal-3 KO mice produced signiﬁcantly higher
(p < 0.01 by unpaired Student's t-test) amounts of IFN-γ, IL-21,
and IL-4 and similar levels of IL-6 and IL-2 compared with CD4+
T cells from WT (Fig. 4a). Accordingly, the frequency of splenic
IFN-γ-producing CD4+ T cells in Gal-3 KO mice was 2.5-fold
higher than that observed in WT controls (Fig. 4b), while no
difference in the frequency of IFN-γ-producing CD8+ T cells, DC
cells, NK cells or NKT cells (Supplementary Fig. 5a–d, respec-
tively) was observed between the experimental groups.
Interestingly, Gal-3 KO mice also exhibited a higher frequency
of IFN-γ-producing B220+ cells than WT controls (Fig. 4c).
Additionally, Tfh contained the highest frequency of IFN-γ-
producing cells and displayed the highest IFN-γ expression
compared with the non-Tfh and Tfr T cell subsets (Fig. 4d). To
investigate whether the B cell-intrinsic deﬁciency in Gal-3
expression affected IFN-γ production, we used the chimeric mice
described in Fig. 3d, in which only B cells lacked Gal-3 signaling.
Fig. 3 B cell-intrinsic Gal-3 deﬁciency favors ASC differentiation in vivo and in vitro and triggers spontaneous GC formation. a Schematic of the adoptive
transfer experiment showing that B cells from Gal-3+/+ WT and Gal-3 KO mice were injected iv into μMT mice. Bar graph showing the seric IgG2c and
IgG3 concentration of recipient μMT mice at 2 weeks after cell transfer (μMT+Gal-3+/+ B cells n= 5; μMT+Gal-3−/− B cells n= 5). b Schematic of the
adoptive transfer experiment showing that non-GC B cells from Gal-3+/+ WT and Gal-3 KO mice were injected iv into CD45.1 WT mice. Bar graph
showing the seric IgG2c and IgG3 concentrations of recipient WT mice at 2 weeks after cell transfer (CD45.1+Gal-3+/+ B cells n= 5; CD45.1+Gal-3−/− B
cells n= 6). c IgG2c and IgG3 concentrations in the supernatants of B cells co-cultured with T cells (ratio 1:1) from the spleen of WT or Gal-3 KO mice and
stimulated for 6 days with anti-CD3 and anti-IgM. The combinations of B and T cells are indicated (n= 4 for each condition). d Schematic of mixed BM
chimeric mice containing a 80:20 ratio of μMT:Gal-3+/+WT or μMT:Gal-3 KO BM cells. e, f Representative plots and statistical analysis of the frequency
of splenic GC B cells (e) and Tfh cells (f) from mixed BM chimeric mice shown in Fig. 3d (n= 7 for each group). g Frequency of splenic Ki-67+ B220+ B
cells (left) and Ki-67+ CD4+ T cells (right) from mixed BM chimeric mice shown in Fig. 3d (n= 7 for each group). h Schematic of mixed BM chimeric mice
containing a 70:30 ratio of CD45.1 Gal-3+/+WT:CD45.2 Gal-3 KO BM cells. i, j Representative plots and statistical analysis of the frequency of splenic GC
B cells (i) and Tfh cells (j) from mixed BM chimeric mice shown in Fig. 3h (n= 9). k Frequency of splenic Ki-67+ B220+ B cells (left) and CD4+ T cells
(right) from mixed BM chimeric mice shown in Fig. 3h (n= 9). Data are the mean ± s.e.m. *p < 0.05, **p < 0.005, ***p < 0.001 (unpaired (a–h) and paired
(i–k) Student’s t-test). Data are representative of three (a–c) or two (d–k) independent experiments
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Selective Gal-3 deﬁciency in B cells increased the frequency of
IFN-γ-producing CD4+ T cells (Fig. 4e), thus indicating that Gal-
3 signaling in B cells is necessary to regulate IFN-γ production by
CD4+ T cells. Next, we decided to evaluate IFN-γ production in
those chimeric mice described in Fig. 3h sharing Gal-3-sufﬁcient
cells and Gal-3-deﬁcient cells. We observed an increased
frequency of IFN-γ-producing CD4+ T cells among Gal-3 KO
CD45.2+ cells in comparison to Gal-3-sufﬁcient WT CD45.1+
cells (Fig. 4f). To analyse how IFN-γ inﬂuence B cell responses in
Gal-3 KO mice, we ﬁrst compared the expression of IFN-γR on B
and T cells from WT and Gal-3 KO mice. We observed that B
cells exhibited higher expression of INF-γR in comparison to
T cells and that INF-γR expression was higher on the cells from
Gal-3 KO mice with respect to WT. Interestingly, GC B cells
(B220+ CD4− FAS+ GL7+) had higher expression of INF-γR
than non-GC B cells (B220+ CD4− FAS− GL7−; Fig. 4g).
Considering that IFN-γ plays a role in T-bet induction in B cells
and is crucial for IgG2c class switching37–39, we also examined T-
bet expression in lymphocytes from WT and Gal-3 KO mice.
Regarding INF-γR, lymphocytes from Gal-3 KO mice expressed
higher levels of T-bet than their counterparts from WT mice
(Fig. 4h, i). We found that GC B cells expressed the highest levels
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of T-bet with respect to other populations indicated (Fig. 4h) and
that T-bet expression was signiﬁcantly higher (p < 0.001 by
unpaired Student's t-test) in Tfh than in non-Tfh cells (Fig. 4i).
Absence of Gal-3 favors autoimmunity. Spontaneous generation
of GC is linked to autoimmunity5, and IFN-γ has also been
associated with spontaneous GC formation and lupus develop-
ment40. Based on our results, it is conceivable that Gal-3 KO mice
may develop autoimmune manifestations. Considering that pro-
gression of autoimmune diseases is age-related and that secretion
of autoantibodies precedes the development of clinical manifes-
tations of lupus41, we evaluated the presence of antinuclear
antibodies (ANA) and tissue damage in 8-month-old Gal-3 KO
mice. We observed that Gal-3 mice exhibited higher antibody
titres (median 1/640) than WT mice (median 1/40) (Fig. 5a). The
most frequent patterns of positivity were as follows: nucleolar,
nuclear homogeneous and nuclear ﬁne speckled (Fig. 5c), which
are frequently associated with SLE. To conﬁrm the ﬁndings of the
ANA positivity measured with the HEp-2 assay and to measure
isotype- and subclass-speciﬁc serum ANA titres, we performed
ELISA and immunoﬂuorescence with Chritidia luciliae slides for
speciﬁc nuclear antigens. Gal-3 KO mice had signiﬁcantly ele-
vated (p < 0.05, p < 0.01, and p < 0.001 by unpaired Student's t-
test) levels of serum IgM, IgG2c, and IgG3 speciﬁc for dsDNA,
Sm/RNP and histone, hallmarks of SLE, in comparison to WT
mice (Fig. 5b–d). No signiﬁcant differences (p > 0.05 by unpaired
Student's t-test) were observed in speciﬁc IgG1 autoantibodies
(Fig. 5d) in serum samples. We also performed a double blinded
score study to evaluate kidney damage in Gal-3 KO compared
with WT mice. Kidneys from 8-month-old Gal-3 KO mice
exhibited an expanded double layer around the glomeruli with
thicker tubules, glomerular hypercellularity and hypercellularity
in the tubulointerstitium compared with age-matched control
mice (Fig. 5e). To characterise the type of inﬁltrate in the tubu-
lointerstitium, we performed immunoﬂuorescence of kidney
slides. We found well-organised lymphoid-like structures wherein
B and T cells were intimately interacting with each other (Fig. 5f).
Finally, we measured urea and creatinine and 24-h urine proteins,
which are important clinical features of renal function. We
observed higher concentrations of creatinine and urine proteins
in Gal-3 KO compared with WT mice, suggesting a loss of renal
function (Fig. 5g, h).
Considering that the emergence of GCs could be age-
dependent, we examined the time-course of these structures in
both groups of mice. GC B cells were barely detectable in spleen
of WT and Gal-3 KO WT mice at weaning (3 weeks old)
(Supplementary Fig. 6a), but this cell subset expanded with age
and was signiﬁcantly increased (p < 0.05 and p < 0.01 by unpaired
Student's t-test, respectively) in spleen of young adult (8-week-
old) and aged (8-month-old) Gal-3 KO mice. Remarkably, and
accompanying the pronounced proliferation of the GC B cell
population, Tfh cells were also increased in 8-month-old Gal-3
KO mice in comparison to their counterparts in WT mice
(Supplementary Fig. 6a).
Compatible with the marked increase in GC B cells, a
signiﬁcantly higher (p < 0.05 by unpaired Student's t-test)
percentage of B cells from 8-month-old Gal-3 KO mice expressed
Bcl-6 (Supplementary Fig. 6b) and exhibited a centroblast
phenotype characterised by high expression of CXCR442
(Supplementary Fig. 6d). Aged Gal-3 KO mice also had an
increased frequency of B cells with the plasmablast/PC phenotype
(B220+ CD4− Blimp-1+) in comparison to WT mice (Supple-
mentary Fig. 6c). Remarkably, B cells from 8-month-old Gal-3
KO presented a higher percentage of CD80+ (Supplementary
Fig. 6e) and CD86+ (Supplementary Fig. 6f) cells than their WT
counterparts.
In agreement with our previous results, aged Gal-3 KO mice
presented abnormally high levels of serum IFN-γ (Fig. 5i).
Considering that Gal-3 negatively regulates Th17 polarisation43
and that Th17 cells may be responsible for aberrant selection of
self-reactive GC B cells and autoantibody formation in BXD2
mice44, we also evaluated IL-17 production in Gal-3 KO mice. No
increased levels of IL-17A were detected in sera from aged Gal-3
KO mice (Fig. 5i).
Blockade of IFN-γ signaling prevents GC reactions and lupus.
We next investigated whether disease can be ameliorated by
blocking IFN-γ. To achieve this goal, 4-week-old female Gal-3
KO mice, which have not yet developed GCs, were treated with
500 µg monoclonal antibody (mAb) anti-IFN-γ every 3 days for
3 weeks. At the end of this treatment, anti-IFN-γ-treated mice
had reduced numbers of GC B cells and Tfh cells than mice
treated with isotype control (Fig. 6a, b, respectively). IFN-γ-
blocked mice exhibited a total absence of PNA+ cells inside the
follicle (Fig. 6c); as expected, untreated Gal-3 KO mice presented
PNA+ GC B cells (Fig. 6c). Interestingly, the follicular B cells of
IFN-γ-blocked Gal-3 KO mice expressed IgD, indicating that, in
the absence of IFN-γ activity, B cells from Gal-3 KO mice did not
experience class-switch recombination (CSR) (Fig. 6d). In addi-
tion, IFN-γ blockade in Gal-3 KO mice signiﬁcantly decreased the
frequency of IFN-γ-producing B and T cells (Fig. 6e, f, respec-
tively) (p < 0.05 and p < 0.05 by unpaired Student's t-test,
respectively) and the frequency of IFN-γR-expressing non-GC
B220+ B cells (Fig. 6g) compared to mice treated with an isotype
control. Finally, we determined that anti-IFN-γ-treated Gal-3
mice had undetectable ANA (Fig. 6h) and presented diminished
mononuclear cell inﬁltrates in the kidney (Fig. 6i) in comparison
to untreated Gal-3 KO mice. Together, the results demonstrate
Fig. 4 Gal-3 KO mice exhibited augmented IFN-γ production. a Quantiﬁcation of IFN-γ, IL-21, IL-4, IL-6, and IL-2 by ELISA in the supernatants of puriﬁed
CD4+ T cells from the spleen of WT and Gal-3 KO mice cultured with anti-CD3 and anti-CD28 for 72 h (n= 4 for each condition). b Representative plots
and statistical analysis of the frequency of splenic IFN-γ-producing CD4+ T cells of WT and Gal-3 KO mice (n= 5 for both strains). c Representative plots
and statistical analysis of the frequency of splenic IFN-γ-producing B220+ B cells of WT and Gal-3 KO mice (n= 5 for both strains). d Representative plots
and statistical analysis of the frequency of splenic IFN-γ-producing non-Tfh, Tfh, and Tfr cells of Gal-3 KO mice (n= 5). e Representative plots and
statistical analysis of the percentage of splenic IFN-γ-producing CD4+ T cells in the mixed BM chimeras shown in Fig. 3d containing an 80:20 ratio of μMT:
Gal-3+/+ WT or μMT:Gal-3 KO BM at 10 weeks after transplantation (μMT+Gal-3+/+ n= 7; μMT+Gal-3−/− B cells n= 7). f Representative plots and
statistical analysis of the percentage of splenic IFN-γ-producing CD4+ T cells in the mixed BM chimeras shown in Fig. 3h containing a 70:30 ratio of
CD45.1 Gal-3+/+WT: CD45.2 Gal-3 KO BM at 10 weeks after transplantation (n= 9). g Representative histograms and statistical analysis of splenic IFN-
γR expression on non-GC and GC B cells and on CD4+ T cells of WT (dotted lines) Gal-3 KO mice (solid lines) (n= 5 for both strains). h Representative
histograms and statistical analysis of T-bet expression in splenic non-GC B cells of WT (n= 5, dotted lines) and Gal-3 KO mice (n= 6, solid lines) and in
GCs from Gal-3 KO mice. i Representative histograms and statistical analysis of T-bet expression in splenic non-Tfh CD4+ T cells of WT (n= 5, dotted
lines) and Gal-3 KO mice (n= 6, solid lines) and in Tfh from Gal-3 KO mice. Data are the mean ± s.e.m. *p < 0.05, **p < 0.005, ***p < 0.001. ns, not
signiﬁcant (unpaired (a–e, g–i) and pair (f) Student’s t-test). a–i Data are representative of three independent experiments
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Fig. 5 Aged Gal-3 KO mice presented signs of autoimmunity. a ANA IgG titres determined using Hep-2 slides in sera from 8-month-old WT and Gal-3 KO
mice. Magniﬁcation: ×100 (top) and ×600 (bottom) (WT n= 9; Gal-3 KO n= 13). Scale bar, 200 μm (upper panels) and 20 μm (lower panels). b dsDNA
IgG determined using Crithidia luciliae slides. Magniﬁcation: ×1200 (WT n= 9; Gal-3 KO n= 13). Scale bar, 10 μm. c Pie charts summarizing the distribution
of serum samples exhibiting the different Hep-2 patterns: Nucleolar; nuclear homogeneous; nuclear ﬁne speckled; nuclear coarse speckled; and non-HEp-2
Reactive. The numbers in the centers of the graphs denote the number of samples analysed per group. Animals with ANA titres higher than 1/40 were
scored as positive (WT n= 9; Gal-3 KO n= 13). d IgM, IgG1, IgG2c, and IgG3 autoantibodies levels speciﬁc for dsDNA, histone and Sm/RNP determined
by ELISA (WT n= 5; Gal-3 KO n= 7). e Kidney sections stained with H&E (left) and the nephritis score (right). Magniﬁcation: ×100 and ×400 (WT n= 10;
Gal-3 KO n= 12). Scale bar (from left to right), 100, 20, 100, and 20 μm. f Immunoﬂuorescence of kidney sections stained with anti-B220 (green), anti-
CD45 (red) and anti-CD4 (blue). Magniﬁcation: ×200 (n= 4 for both strains). Scale bar, 100 μm. g, h Urea (left) and creatinine (right) concentrations in
sera (g) and protein levels in 24-h urine samples (h) from 8-month-old WT and Gal-3 KO mice (WT n= 4; Gal-3 KO n= 7). i IFN-γ and IL-17
concentrations in sera from 8-month-old WT and Gal-3 KO mice (n= 5 for both strains). Data are the mean ± s.e.m. *p < 0.05, **p < 0.005, ***p < 0.001.
ns not signiﬁcant (unpaired Student’s t-test). All experiments were performed in 8-month-old WT (green) and Gal-3 KO (blue) mice. a, c, e Data are
representative of four independent experiments. b, d Data are representative of two independent experiments. f–i Data are representative of three
independent experiments
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Fig. 6 IFN-γ signaling blockade prevents spontaneous GC formation and lupus-like disease. a, b Representative plots and statistical analysis of the
frequency of GC B cells and Tfh cells in the spleen of Ig-control Gal-3 KO (Ctrl) and anti-IFN-γ-treated Gal-3 KO mice (αIFN-γ), respectively (n= 5 for each
group). c Immunoﬂuorescence of frozen spleen sections (7 μm) from Ctrl and αIFN-γmice stained with anti-CD4 (green), anti-B220 (red) and PNA (blue).
Magniﬁcation: ×100 (top) and ×400 (bottom) (n= 5 for each group). Scale bar, 200 μm (upper panels) and 50 μm (lower panels). d Immunoﬂuorescence
of frozen spleen sections (7 μm) from Ctrl and αIFN-γ mice stained with PNA (green), anti-IgD (red) and anti-B220 (blue). Magniﬁcation: 4×00 (n= 5 for
each group). Scale bar, 50 μm. e Representative plots and statistical analysis of the frequency of IFN-γ-producing B220+ cells in the spleen of Ctrl and
αIFN-γ mice (n= 5 for each group). f Representative plots and statistical analysis of the frequency of IFN-γ-producing CD4+ T cells in the spleen of Ctrl
and αIFN-γ mice (n= 5 for each group). g Representative plots and statistical analysis of the frequency of B220+ GL7− FAS− non-GC IFN-γR+ B cells in
the spleen of Ctrl and αIFN-γmice (n= 5 for each group). h ANA IgG determined with Hep-2 slides in sera from Ctrl and αIFN-γmice. Magniﬁcation: ×100
(top) and x400 (bottom) (n= 5 for each group). Scale bar, 200 μm (upper panels) and 50 μm (lower panels). i Kidney sections from Ctrl and αIFN-γ mice
stained with H&E. Magniﬁcation ×100 (top) and ×400 (bottom) (n= 5 for each group). Scale bar, 100 μm (upper panels) and 20 μm (lower panels). Ig-
Control Gal-3 KO mice (Ctrl) are indicated in blue and αIFN-γ-treated Gal-3 KO mice (αIFN-γ) in violet. Data are the mean ± s.e.m. *p < 0.05 (unpaired
Student’s t-test). a–i Data are representative of two independent experiments
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that in Gal-3 KO mice, IFN-γ overproduction leads to (induces
and is required to sustain) a pathogenic and lupus-inducing GC
response.
Discussion
Our ﬁndings provide the ﬁrst evidence for the involvement of
Gal-3 as a key molecule in the GC reaction. Previously, we and
others have found that Gal-3 regulates B cell niches in lymph
node tissues and inhibits PC differentiation in vitro17 and
in vivo45. Our studies revealed that Gal-3 is expressed by resting B
cells, as previously reported17, and is downregulated after acti-
vation with a T-independent (LPS) or T-dependent (CD40L+IL-
4) stimulus that favor B cell differentiation into PCs, suggesting
that the downregulation of Gal-3 may be necessary to favor the
ASC programme. Accordingly, we demonstrated that mice lack-
ing Gal-3 have hypergammaglobulinemia and an increased fre-
quency of ASCs in the spleen and BM. We found increased levels
of IgG2c and IgG3 in Gal-3 KO mice. These Ig subclasses efﬁ-
ciently activate stimulatory FcγRs and complement, and they
display the highest pathogenic activity of the Igs46. It is well
known that the productions of these Ig subclasses is promoted by
IFN-γ47 and that they are closely involved in the development
and progression of autoantibody-mediated autoimmune diseases,
such as lupus. Here we show that, without purposeful immuni-
zation or infection, Gal-3 KO mice exhibit spontaneous GC
generation in the spleen. The increase in number of GC B cells
was time-dependent since GC structures appeared after 4 weeks
of birth and increased with age. The increase in B cells with GC
phenotype was accompanied by an expansion of Tfh cells.
Additionally, the Tfh:Tfr ratio was signiﬁcantly higher in these
mice compared with their WT counterparts. It has been described
that the balance between Treg and effector T cell is critical for
proper control of the quality and magnitude of adaptive immune
responses and for establishing or breaching tolerance to self- and
non-self-antigens48,49. Therefore, the increase in the ratio of Tfh
to Tfr cells in Gal-3 KO mice could have an impact on promoting
the development of GCs in Gal-3 KO mice, resulting in uncon-
trolled GC reactions and subsequent development of an auto-
immune disease50,51.
To better understand the relationship between Gal-3 and the B
cell differentiation programme, we compared gene expression
levels between B cells from WT or Gal-3 KO mice. Gal-3 KO
mice showed increased expression of genes related to B cell
activation and GC-formation, such as Mki67, Aicda, Lilrb4, Itga1,
Ig heavy chain-encoding genes and others. Interestingly, we
found increased transcript levels of miRs, which coordinate GC
formation, CSR/SHM, PC differentiation, and memory B cell
differentiation, such as miR-15531 and miR-21733. These short
non-coding RNAs would individually target multiple factors in
addition to regulating AID, Bcl-6 and Blimp-1. Likewise, we
found quite a few miRs with as yet unidentiﬁed functions, which
were differentially expressed in B cells from Gal-3 KO and WT
mice and could inﬂuence GC reaction development. Given the
ability of Gal-3 to bind to different molecules, such as RNA52;
adaptor proteins involved in protein transport, such as Alix53;
transcription factors, such as Bcl-254; and components of the
nuclear ribonucleoprotein complex55, it is likely that Gal-3 could
act a gene regulator, either directly or indirectly.
Analysis of molecules that have a critical role in regulating the
GC reaction revealed that Gal-3 KO mice had higher percentages
of CD80+ and CD86+ B cells, and after a TLR-stimulated B cells
from Gal-3 KO mice had increased expression of CD80 in
comparison to B cells from WT mice. It has been reported that B
cell expression of CD80 plays a critical role in both early and late
GC responses56. Moreover, high expression of CD80 and CD86
molecules is evident on freshly isolated B cells in patients with
SLE57. In our model, the increased percentage of CD80 and CD86
B cells in Gal-3-deﬁcient mice possibly facilitated Tfh induction,
which in turn could allow the GC response. This hypothesis
favors the induction of B cell activation and autoantibody pro-
duction. It is possible that the increase in expression of CD80 and
CD86 resulted from the increased concentrations of IFN-γ
detected in Gal-3 KO mice rather than a direct effect of Gal-3 in
regulating the expression of these proteins, as it has been reported
that IFN-γ increases the expression of these molecules on B
cells58.
A question that arises is whether spontaneous GCs develop-
ment was induced by the lack of Gal-3 expression speciﬁcally in B
cells or if B and T cells are co-protagonists of the exacerbated GC
reaction. Adoptive transfer of naive B cells into B cell-deﬁcient
μMT mice or WT mice showed that, in any case, serum levels of
IgG2c and IgG3 were increased only in mice transferred with Gal-
3-deﬁcient B cells. The data suggest that B cells deﬁcient in Gal-3
can differentiate and secrete Igs independently of a Gal-3-
sufﬁcient environment. In addition, co-cultures of naive B and T
cell from WT and Gal-3 KO mice showed that stimulated Gal-3-
deﬁcient B cells produced higher levels of Igs in comparison to
Gal-3-sufﬁcient B cells and that the addition of Gal-3-deﬁcient
T cells did not increase that production. Using chimeric mice, we
were able to show that the lack of Gal-3 in B cells is, by itself,
sufﬁcient to trigger disruption of immunological tolerance and to
favor the generation of spontaneous GCs. By contrast, evidence
provided by other groups has shown that the absence of Gal-3
would also regulate certain functions of CD4+ T cells. Huan-
Yuan Chen et al. found that Gal-3 is an inhibitory regulator of T-
cell activation and functions intracellularly by promoting TCR
downregulation53. In our work, we also observed that CD4+ cells
could produce more IFN-γ (probably by signals provided by Gal-
3-deﬁcient B cells), and we hypothesise that, although not
responsible for triggering spontaneous GC formation, they con-
tribute to maintaining and propagating the autoimmune condi-
tion mediated by IFN-γ.
Spontaneous GC B cells and Tfh cells play a crucial role in
generating high-afﬁnity pathogenic autoantibodies in many
autoimmune diseases7,10,59–62. Accordingly, in Gal-3 KO mice,
we found ANAs (including anti-dsDNA, anti-Histone and anti-
SM/RNP) and kidney disease, both of which are cardinal features
of systemic autoimmune diseases, such as lupus. Interestingly,
Gal-3 KO mice also presented well-organised lymphoid-like
structures wherein B and T cells intimately interacted within each
other. This observation suggests that these T:B aggregates in the
kidneys promote the local secretion of pathogenic autoantibodies
that contribute to the lupus-like phenomena. Thus, Gal-3 KO
mice exhibited higher concentrations of creatinine in sera and 24-
h urine proteins compared with WT mice, suggesting a loss of
renal function.
Interestingly, according to the serum Ig isotype proﬁle, we
observed high levels of serum IFN-γ and increased numbers of
IFN-γ-producing cells in Gal-3 KO mice. Increased IFN-γ
expression alone can result in the development of systemic
autoimmunity, as documented by the ﬁnding that epidermal
transgenic expression of IFN-γ leads to anti-dsDNA and anti-
histone autoantibodies and glomerulonephritis63. The ability of
IFN-γ to promote IgG class switching to more pathogenic auto-
antibodies (IgG2c and IgG3 in mice) and activation of IgG Fc
receptors and complement could also contribute to disease
severity64. Mutation of ROQUIN (Rc3h1) in Roquinsan/san mice,
another model of lupus, leads to reduced decay of IFN-γ mRNA,
resulting in increased IFN-γ signaling and accumulation of Tfh
cells, culminating in an increase in GC B cells and auto-
antibodies7. Notably, IFN-γR plays a crucial role in the
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development of autoimmune conditions, and it was clearly
demonstrated recently in several mouse models7,65,66. Interest-
ingly, in Gal-3 KO mice, B cells as well as T cells expressed higher
levels of IFN-γR in comparison to WT, suggesting that the
absence of Gal-3 conditioned both lymphocyte populations
toward a better IFN-γ signaling response.
A relationship has been observed between the lack of Gal-3 and
increased levels of IFN-γ. Higher serum levels of IFN-γ have been
shown in melanoma-bearing Gal-3 KO mice67, and CD4+ T cells
incubated with Gal-3 knockdown DCs produced more IFN-γ
than control cells68. Recently, Tseng and collaborators showed
that Gal-3 may decrease IFN-γ signaling by facilitating AKT/
GSK-3b/SHP2 signaling69.
Additionally, a possible link has been proposed between
commensal microbiota and autoimmunity70. We observed that B
cells from Gal-3 KO mice were more sensitive to LPS (Supple-
mentary Fig. 6g) than B cells from WT mice. These results,
together with the observation that GCs appear in Gal-3 KO mice
after the suckling period, lead us to hypothesize that the microbial
ﬂora could be a stimulus that induces B cells to differentiate into
GC B cells. However, when Gal-3 KO mice were treated with a
mixture of antibiotics to deplete the murine intestinal microbiota,
no changes were observed in the frequency of either splenic GC B
cells or Tfh in comparison to untreated mice (Supplementary
Fig. 7a, b). Likewise, co-housed experiments between mutant Gal-
3 KO and WT mice revealed no induction of GCs in WT mice
nor prevention of spontaneous GCs in Gal-3 KO mice (Supple-
mentary Fig. 7b), suggesting that ligands from the gut microbiota
are not involved in the induction of the self-reactive GCs in Gal-3
KO mice.
Herein, we report complete dependence of the presence of self-
reactive GCs on IFN-γ in Gal-3 KO mice. IFN-γ blockade limited
the induction of spontaneous GC responses, reducing GC B cell
and Tfh cell frequencies and Ig class switching as well as pre-
venting the appearance of autoantibodies and kidney inﬁltrate;
these ﬁndings demonstrated that IFN-γ overproduction was
required to sustain lupus-like disease. In conclusion, we revealed
a new undeﬁned role of Gal-3 expression in controlling GC
formation and, consequently, immune tolerance. Our ﬁndings
demonstrate that the absence of Gal-3 in B cells intrinsically
favors GC formation and highlight the potential for therapeutic
targeting of this pathway in autoimmunity.
Methods
Mice. All animal experiments were approved by and conducted in accordance with
the guidelines of the Institutional Animal Care and Use Committee of the Facultad
de Ciencias Químicas, Universidad Nacional de Córdoba (Approval Number HCD
1525/14), in strict accordance with the recommendation of the Guide to the Care
and Use of Experimental Animals published by the Canadian Council on Animal
Care (OLAW Assurance number A5802-01). Mice used for experiments were
female and age-matched (3 and 8 weeks old and 8 months old) and housed with a
12-h light-dark cycle. C57BL/6 wild type (WT; JAX:000664) mice were obtained
from The Jackson Laboratories (USA). B6.Cg-Lgals3tm1Poi/J (Gal-3 KO;
JAX:006338), C57BL/6 CD45.1 mice (B6.SJL-Ptprca Pepcb/Boy; JAX:002014) and
μMT mice (B6.129S2-Ighmtm1Cgn/J; JAX:002288) were obtained from The
Jackson Laboratories (USA). All animals were bred and housed under barrier,
temperature and humidity-controlled conditions at the Animal Facility of CIBICI-
CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba.
Animals were euthanized with carbon dioxide (CO2) followed by cervical
dislocation.
Cell culture. Spleens were obtained and homogenised through a tissue strainer.
Bone marrow (BM) cells were isolated by ﬂushing femurs and tibias of mice with
RPMI 1640. Cells were resuspended in a Tris-ammonium chloride buffer for 5 min
to lyse red blood cells.
Splenic B cells were puriﬁed using a negative B cell isolation kit following
manufacturers’ guidelines (Miltenyi Biotec; Cat#130-049-801), or they were
positively selected (B220+ CD3− CD4−) by cell sorting with a FACSAria II (BD
Biosciences) after staining with ﬂuorochrome-conjugated anti-B220, anti-CD3 and
anti-CD4. Both methods yielded enriched populations >93%.
For splenic CD4+ T cell puriﬁcation, spleen cell suspensions were stained with
ﬂuorochrome-conjugated anti-CD3, anti-CD4 and anti-B220, and CD3+ CD4+
B220− T cells were sorted with a FACSAria II (BD Biosciences). For co-culture
experiments, spleen cell suspensions were stained with ﬂuorochrome-conjugated
anti-CD4, anti-B220 and anti-GL7, and CD4+ B220− GL7− T cells and B220+
CD4− GL7− B cells were obtained by sorting with a FACSAria II (BD Bioscience)
and were >95% pure.
B1 cells were puriﬁed from total peritoneal cells obtained from washes of the
peritoneal cavity of WT mice with 2% FBS-PBS and stained with ﬂuorochrome-
conjugated anti-mouse CD19, anti-mouse B220, anti-mouse CD3 and anti-mouse
CD11b antibodies. B1 cells were positively selected by CD19+ B220+ CD11b+ CD3−
expression with a FACSAria cell sorter (BD Biosciences).
Follicular B2 cells (B220+ CD21+ CD23high CD3−CD4−) were obtained from
spleen of WT mice by cell sorting using ﬂuorochrome-conjugated anti-mouse
B220, anti-mouse CD21, anti-mouse CD23 antibodies, anti-mouse CD3, and anti-
mouse CD4.
The speciﬁc cell population and gating strategy in each case are described in
Supplementary Fig. 8.
All cell cultures were performed in complete RPMI: RPMI 1640 (Gibco, Life
Technologies) medium supplemented with 2 mM glutamine (Gibco, Life
Technologies), 50 μM 2-ME (Sigma), and 40 μg/ml gentamicin (Fabra
Laboratories) containing 10% FBS (PAA).
In some experiments, B cells (2 × 106) were cultured in complete RPMI in the
absence or presence of LPS (Invivogen, 5 μg/mL) for different times (12, 24, 48 and
72 h) or with LPS or anti-CD40 (3 μg/ml) plus rmIL-4 (10 ng/ml) for 72 h. CD4+
T cells were cultured in complete RPMI at 37 °C in a 96-well plate (Corning)
precoated with anti-CD3 (Biolegend, 1 μg/mL) plus anti-CD28 (Biolegend, 2 μg/
mL) for 72 h.
Flow cytometry. For surface staining, single-cell suspensions were washed in ice-
cold FACS buffer (PBS-2% FBS) and incubated with ﬂuorochrome labelled-
antibodies for 20 min at 4 °C. For intracellular cytokine staining, cells were sti-
mulated for 5 h with 50 ng/mL PMA (phorbol 12-myristate 13-acetate), 500 ng/mL
ionomycin and GolgiStop (BD Biosciences). After surface staining, cells were ﬁxed
and permeabilized with Cytoﬁx/Cytoperm according to the manufacturer’s
instructions (BD Biosciences; Cat#554714). For intracellular Foxp3, Bcl-6, Blimp-1,
and Ki-67 staining, a Foxp3 Fix/Perm kit was used (eBiosciences; Cat#00-5523-00)
after surface staining. Data were collected on a FACSCanto (BD Biosciences) and
were analysed with FlowJo software (TreeStar).
Antibodies. The following anti-mouse antibodies were used for FACS (Supple-
mentary Table 1): B220-FITC (RA3-6B2), B220-PE (RA3-6B2), B220-PE-Cy7
(RA3-6B2), CD3-PerCP-Cy5.5 (145-2C11), CD86-APC (GL-1), CD4-APC-Cy7
(GK1.5), CD23-FITC (B3B4), IFN-γ-FITC (XMG1.2), Bcl-6-PE (7D1), IL-21R-
APC (4A9), Streptavidin-PerCP-Cy5.5, NK1.1-PE-Cy7 (PK136), TCR-β-chain-
APC (H57-597), ICOS-PE-Cy7 (C398.4A), and IFN-γRα-Biotin (2E2) were from
Biolegend; B220-APC (RA3-6B2), CD11b-FITC (M1/70), CD21-PE (eBio8D9),
PD-1-PE (J43), CD4-PE (GK1.5), CXCR4-PE (2B11), CD40-PE (1C10), CD69-
PerCP-Cy5.5 (H1.2F3), Foxp3-PerCP-Cy5.5 (FJK-16s), Foxp3-APC (FJK-16s),
IFN-γ-APC (XMG1.2), Ki-67-eFlur660 (SolA15), GL7-eFluor660 (GL7), CD11c
PE-Cy7 (N418), MHC Class II I-Ab PerCP-eFluor710 (AF6-120.1), CD49b PE
(DX5), CTLA-4 PE (UC10-4B9) and CD39 PerCP-eFluor710 (24DMS1) were from
eBioscience; CD11c-FITC (HL-3), CD45.1-APC-Cy7 (A20), CD45.2-PerCP-Cy5.5
(104), IL-17-PE (TC11-18H10), Bcl-6-PE-Cy7 (K112-91), CD80-PE (16-10A1),
CD138-APC (281-2), FAS (CD95)-PE (Jo2), FAS (CD95)-PE-Cy7 (Jo-2), FAS-
Biotin (Jo2), Streptavidin-PE, CXCR5-Biotin (2G8) and IgD FITC (11-26c.2a) and
CD38 PE (90) were from BD Biosciences; and Blimp-1-PE (C-21) was from Santa
Cruz.
The following anti-mouse antibodies were used for tissue immunoﬂuorescence:
PNA-FITC was from Vector Laboratories; PNA-Alexa Fluor 647, CD4-Alexa Fluor
488 (RM4-5), CD3-Alexa Fluor 647 (500A2) and IgG(H+ L)-Alexa Fluor 594 were
from Invitrogen; IgD-Alexa Fluor 594 (11-26c.2a) was from Biolegend, B220-PE
(RA3-6B2) and B220-APC (RA3-6B2) were from eBioscience.
In vitro co-culture of T and B cells. Sorted 1.105 naive T cells (CD4+ GL7− B220−)
from WT or Gal-3 KO mice were co-cultured with 1.105 naive B cells (B220+ GL7−
CD4−) from WT or Gal-3 KO mice in a 96-well plate in the presence of 2 μg/mL
soluble anti-CD3 (2C11) and 5 μg/mL anti-IgM (Jackson Immunoresearch).
After 6 days of culture, the Igs concentration in the supernatants was measured by
ELISA.
Western blot analysis. To detect Gal-3, 35 μg whole cell lysates in radio-
immunoprecipitation assay buffer were mixed with 6 μL sample buffer and boiled
for 5 min. Cell lysates were resolved by 12.5% SDS-PAGE. Monoclonal anti-Gal-3
B2C10 (diluted 1:500) (Santa Cruz Biotechnology) was used to detect Gal-3. As a
control for protein loading, nitrocellulose membranes were reproved with 0.25 mg/
mL anti-β-actin antiserum (Santa Cruz Biotechnology) or with a polyclonal anti-
calreticulin antibody (Santa Cruz Biotechnology) (diluted 1:2000). The levels of
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proteins were analysed by Scion Image 1.62C alias. Uncropped original scans of
immunoblots are provided in Supplementary Fig. 9.
Adoptive transfer. Sorted B cells from CD45.2 WT or CD45.2 Gal-3 KO mice
were transferred intravenously into recipient mice. B cells (2 × 107/mouse) were
transferred when µMT mice were the recipients and 6 × 106 B cells were transferred
per mouse when CD45.1+ mice were the recipients. Mice were rested for 2 weeks
and bled to determine serum IgG2c and IgG3 concentrations.
Generation of BM chimeras. For the BM chimeras shown in Fig. 3d, C57BL/6
recipient mice were lethally irradiated with 100 Gy (137Cs source) and reconstituted
via intravenous injection with a combination of an 80:20 mixture of 10.106 BM
cells from B6.129S2-Ighmtm1Cgn/J (μMT) plus C57BL/6 (WT) or (μMT) plus Gal-3
KO donors, respectively. For the BM chimeras shown in Fig. 3h, CD45.2 C57BL/6
recipient mice were lethally irradiated with 100 Gy and reconstituted via intrave-
nous injection with a combination of a 30:70 mixture of 10 × 106 BM cells from B6.
Cg-Lgals3tm1Poi/J (Gal-3 KO) and CD45.1 C57BL/6 (CD45.1- Gal-3+/+) donors,
respectively. For both chimeras, experiments were performed 8–10 weeks after
reconstitution.
Anti-IFN-γ treatment. Three-week-old female Gal-3 KO mice were bled prior to
treatment and then injected ip with 500 μg anti-IFN-γmonoclonal (BioXcell, clone:
XMG 1.2) (anti-IFN-γ treated Gal-3 KO mice) or 500 μg rat IgG1 Isotype control
mAb (BioXcell) (Ig-control Gal-3KO mice) every 3 days for 3 weeks.
Antibiotic treatment. Three-week old mice were treated for 5 weeks with van-
comycin (500 mg/L; Cat#V1130-1G), neomycin sulphate (1 g/L; Cat#N6386-25G),
and metronidazole (1 g/L; Cat#M3761-25G) in drinking water (all from Sigma-
Aldrich). Antibiotic-containing water was changed twice a week.
Immunoglobulin and cytokine quantiﬁcation. Total IgM and IgG isotype levels
were determined by ELISA in sera. Plates were coated with 10 μg/mL of the
isotype-speciﬁc goat anti-mouse antibody (IgM, IgG1, IgG2c, IgG2b, and IgG3;
SouthernBiotech) overnight at 4 °C and blocked with 1% BSA. Sera were incubated
overnight at 4 °C. Peroxidase-conjugated anti-mouse IgM or IgG isotypes were
added and incubated for 1 h at 37 °C. The reaction was developed with TMB
Substrate Reagent (BD Biosciences), followed by quantiﬁcation on a Microplate
Reader 450 from Bio-Rad. The concentration was measured with reference to
standard curves using known amounts of the respective murine immunoglobulin
isotypes (SouthernBiotech).
Cytokines were determined by ELISA in mouse serum and in the supernatant of
sorted splenic T cells (CD4+ B220−) from WT and Gal-3 KO mice cultured
in vitro with anti-CD3 plus anti-CD28 for 72 h. ELISA was performed with paired
antibodies from eBioscience for mouse IFN-γ (Cat#88-7314-77), IL-21 (Cat#88-
8210-88), IL-4 (Cat#88-7044-77), IL-6 (Cat#88-7064-88) and IL-2 (Cat#88-7024-
77), according to the manufacturer’s instructions.
ELISPOT assay. For analysis of the production of ASC by ELISPOT, plates were
coated with 10 µg per well of goat anti-mouse Ig (H+ L) (Southern Biotech) in
sodium bicarbonate buffer and then blocked with 2% BSA/PBS. Cells from spleens
or from BM were serially diluted across the plate and then incubated for 4–6 h at
37 °C. Biotin-goat anti-Ig, goat anti-IgM, or goat anti-IgG (Southern Biotech)
diluted in blocking buffer was added, followed by three washes with 0.1% Tween 20
and a secondary incubation with ExtrAvidin-alkaline phosphatase (Sigma-Aldrich).
Spots were detected using BCIP/NBT (Sigma-Aldrich) and scanned and counted
with an ImmunoSpot Analyzer (Cellular Technology).
Immunoﬂuorescence analysis of B cell suspensions and tissues. Puriﬁed B cells
cultured in medium or with LPS (10 µg/mL) for 72 h were washed once with PBS
and spun down onto a slide using a Cyto-Spin system. For the ﬁxation procedure, B
cells were treated with 3% p-formaldehyde in PBS for 20 min at RT. Endogenous
ﬂuorescence was quenched by incubation with 10 mM NH4Cl. B cells were per-
meabilized with 0.5% Nonidet P-40 diluted in PBS pH 7.4 for 20 min at RT.
Nonspeciﬁc binding was blocked, and then B cells were incubated with FITC-
labelled anti-Gal-3 diluted in DAKO Diluent with Background Reducing Com-
ponents solution (Dako, Carpinteira, CA, USA). DAPI was used for nuclear
counterstaining. Cells were mounted with DAKO Fluorescent Mounting Medium
(Dako), and immunoﬂuorescence was evaluated using a Nikon Eclipse TE-2000U
microscope (Nikon Corporation; Tokyo, Japan).
For tissue immunoﬂuorescence, spleens from WT and Gal-3 KO mice were
collected and frozen over liquid nitrogen. Frozen sections with a thickness of 7 μm
were cut, ﬁxed for 10 min in cold acetone, left to dry at 25 °C and stored at −80 °C
until use. Slides were hydrated in TRIS buffer and blocked for 30 min at 25 °C with
10% normal mouse serum in TRIS buffer. After blockade, slides were incubated for
50 min at 25 °C with the different antibodies diluted in TRIS Buffer. Slices were
mounted with FluorSave (Merck Millipore). Images were collected with an
Olympus microscope (FV1000), and those recorded in the far-red channel were
pseudo-coloured blue.
ANA assessment. For ANA detection, serum was serially diluted in PBS from 1:20
to 1:1280 for indirect immunoﬂuorescence on ﬁxed HEp-2 slides (BioSystems S.A.)
and for indirect immunoﬂuorescence of ﬁxed Crithidia luciliae slides (Antibodies,
Inc.) serum diluted 1:20 for anti-dsDNA antibody detection. Slides were incubated
with 20 µL of serum for 45 min, followed by an incubation with Alexa Fluor 488-
labelled goat anti-mouse IgG (Invitrogen) for 20 min. Slides were observed with an
Olympus microscope (FV1000) at different magniﬁcations.
Measurements of speciﬁc autoantibodies. For speciﬁc auto-Ab, 96-well plates
were precoated overnight at 4 °C with 100 µg/mL calf thymus dsDNA (D3664-5 ×
2MG; Sigma-Aldrich), 5 µg/mL Sm/RNP (ATR01-10; Arotec Diagnostic Limited)
or 5 µg/mL histone (ATH01-02; Arotec Diagnostic Limited). Plates were blocked
for 1 h with 1% BSA in PBS before addition of diluted serum for 2 h. Speciﬁc
antibodies were detected using goat anti–mouse IgM-HRP, IgG-HRP, IgG1-HRP,
IgG2c-HRP, or IgG3-HRP (SouthernBiotech), and peroxidase reactions were
developed using TMB Substrate Reagent (BD Biosciences), followed by quantiﬁ-
cation at 450 nm on a Microplate Reader 450 from Bio-Rad. The results are
expressed in optical density (OD) units.
Histology. Kidneys were ﬁxed in 10% neutral-buffered formalin and embedded in
parafﬁn. Seven-micron-thick parafﬁn-embedded sections were dewaxed and
stained with haematoxylin and eosin (H&E). The images were captured using a
digital camera Carl Zeiss Microimaging GmbH, with Moticam 2000. Each kidney
was examined at 400× magniﬁcation and scored from 0 to 12 based on the fol-
lowing features: glomerular size and hypercellularity (0–4), changes in glomerular
matrix (0–4) and the degree of hypercellularity in the tubulointerstitium (0–4).
Pathology was scored by observers who were blinded to the genotype.
For kidney IF staining, kidneys from WT and Gal-3 KO mice were collected
and frozen over liquid nitrogen. Frozen sections with a thickness of 7 μm were cut,
ﬁxed for 10 min in cold acetone, left to dry at 25 °C and stored at −80 °C until use.
Slides were hydrated in TRIS buffer and blocked for 30 min at 25 °C with 10%
normal mouse serum in TRIS buffer. After blockade, slides were stained with anti-
B220-Alexa Fluor 488, anti-CD45-Alexa Fluor 555 and anti-CD4-Alexa Fluor 647
in TRIS Buffer. Slices were mounted with FluorSave (Merck Millipore). Images
were collected with an Olympus microscope (FV1000).
Urea and creatinine determination. Urea and creatinine concentrations were
determined on a Dimension RxL Max system (enzymatic/colorimetric method and
Jaffé reaction, respectively; Siemens Healthcare Diagnostics), following the man-
ufacturer’s instructions.
Proteinuria. Urine samples were collected 24 h by placing mice in custom-made
mouse metabolic cages. Urine total protein was determined on a Dimension RxL
Max system (colorimetric method; Siemens Healthcare Diagnostics), following
manufacturer’s instructions.
DNA microarrays. For gene-expression analysis, puriﬁed B cells from 8-week-old
WT and Gal-3 KO mice were lysed with TRIzol reagent. Total RNA was extracted
with the RNAeasy Mini Kit (Qiagen). RNA quality was veriﬁed in an Agilent
Bioanalyser and measured with a Nanodrop 1000 (Thermo Scientiﬁc). Microarray
experiments were performed on GeneChip Mouse Gene 2.1 ST arrays (Affymetrix).
The working lists were created by ﬁltering probes with detection P values <0.05 for
all chips and discarding overlapping probes. Each dataset was derived from two
biologically independent replicate samples. Independent samples were compared
by computing fold ratios and ﬁltered at a 1.2-fold threshold for Venn diagrams and
pathway analysis. For pathway analysis, GenBank accession numbers were mapped
to the Ingenuity database (IPA, http://www.ingenuity.com) to retrieve relevant
biological processes. Heat maps were generated using the web interface programme
Matrix2png.
Statistical analysis. All data are expressed as mean ± s.e.m. Replicates were bio-
logical replicates and n represents the number of individual mice analysed per
experiment. Mice were assigned to groups at random for all mouse studies and,
where possible, mixed among cages. Careful consideration has been given to cal-
culate the number of mice needed to give statistically signiﬁcant results, while using
the minimum number of mice possible. Numbers of mice for each experiment were
decided after consultation with a statistician at UNC. Experiments were performed
independently in triplicate to control for experimental variation. No exclusion was
performed. Statistical comparisons were determined using unpaired or paired two-
tailed Student’s t-test or one-way analysis of variance (ANOVA) followed by
Tukey–Kramer multiple comparison test when appropriate. Statistical analyses
were performed using GraphPad Prism software (GraphPad). Data followed
Gaussian distribution with similar variance between groups that were compared.
Differences were considered statistically signiﬁcant when the P values <0.05.
Data availability. The microarray data have been deposited in the ArrayExpress
database under accession number E-MTAB-6053. The authors declare that the data
supporting the ﬁndings of this study are available within the article and
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